Wharton's Jelly-Derived Mesenchymal Stem Cell Exosomes

exosome therapy derived from Wharton’s jelly mesenchymal stem cells · Kafrelsheikh University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Wharton's Jelly-Derived Mesenchymal Stem Cell Exosomes, covering 2025-04-29 to 2025-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Wharton's Jelly-Derived Mesenchymal Stem Cell Exosomes in the Treatment of Diabetic Foot Ulcers: A Double-blinded Randomized Controlled Clinical Trial [Phase 1]

See pricing